Preemptive kidney transplantation: Has it come of age?

Yihung Huang, Millie Samaniego

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

The benefits of preemptive kidney transplantation are manifold. By avoiding complications associated with dialysis, preemptive kidney transplantation offers significant benefits in terms of patient welfare and societal cost-saving. Patients transplanted preemptively also tend to enjoy better patient and graft survival, especially when done with a living-donor organ. While dialysis exposure limited to 6 to 12 months may not significantly impact post-transplant outcomes, longer period of dialysis has been shown to increase the risk of mortality, delayed graft function, acute rejection, and death-censored graft loss. The benefits of preemptive transplantation also extend to different age groups and end-stage kidney disease (ESKD) diagnoses. However, multiple barriers have prevented wider adoption of preemptive transplantation as the primary treatment of ESKD around the world. Timely preparation for ESKD and identification of living donors should be encouraged in all patients with advanced chronic kidney disease to increase the chance of preemptive transplantation.

Original languageEnglish (US)
Pages (from-to)428-432
Number of pages5
JournalNephrologie et Therapeutique
Volume8
Issue number6
DOIs
StatePublished - Nov 1 2012
Externally publishedYes

Fingerprint

Kidney Transplantation
Chronic Kidney Failure
Dialysis
Transplantation
Living Donors
Delayed Graft Function
Transplants
Graft Survival
Chronic Renal Insufficiency
Age Groups
Costs and Cost Analysis
Mortality
Therapeutics

Keywords

  • Graft survival
  • Patient selection
  • Patient survival
  • Transplant outcomes

ASJC Scopus subject areas

  • Nephrology

Cite this

Preemptive kidney transplantation : Has it come of age? / Huang, Yihung; Samaniego, Millie.

In: Nephrologie et Therapeutique, Vol. 8, No. 6, 01.11.2012, p. 428-432.

Research output: Contribution to journalReview article

Huang, Yihung ; Samaniego, Millie. / Preemptive kidney transplantation : Has it come of age?. In: Nephrologie et Therapeutique. 2012 ; Vol. 8, No. 6. pp. 428-432.
@article{590a05e1dc874f848b1ccdee2bbda82c,
title = "Preemptive kidney transplantation: Has it come of age?",
abstract = "The benefits of preemptive kidney transplantation are manifold. By avoiding complications associated with dialysis, preemptive kidney transplantation offers significant benefits in terms of patient welfare and societal cost-saving. Patients transplanted preemptively also tend to enjoy better patient and graft survival, especially when done with a living-donor organ. While dialysis exposure limited to 6 to 12 months may not significantly impact post-transplant outcomes, longer period of dialysis has been shown to increase the risk of mortality, delayed graft function, acute rejection, and death-censored graft loss. The benefits of preemptive transplantation also extend to different age groups and end-stage kidney disease (ESKD) diagnoses. However, multiple barriers have prevented wider adoption of preemptive transplantation as the primary treatment of ESKD around the world. Timely preparation for ESKD and identification of living donors should be encouraged in all patients with advanced chronic kidney disease to increase the chance of preemptive transplantation.",
keywords = "Graft survival, Patient selection, Patient survival, Transplant outcomes",
author = "Yihung Huang and Millie Samaniego",
year = "2012",
month = "11",
day = "1",
doi = "10.1016/j.nephro.2012.06.004",
language = "English (US)",
volume = "8",
pages = "428--432",
journal = "Nephrologie et Therapeutique",
issn = "1769-7255",
publisher = "Elsevier Masson",
number = "6",

}

TY - JOUR

T1 - Preemptive kidney transplantation

T2 - Has it come of age?

AU - Huang, Yihung

AU - Samaniego, Millie

PY - 2012/11/1

Y1 - 2012/11/1

N2 - The benefits of preemptive kidney transplantation are manifold. By avoiding complications associated with dialysis, preemptive kidney transplantation offers significant benefits in terms of patient welfare and societal cost-saving. Patients transplanted preemptively also tend to enjoy better patient and graft survival, especially when done with a living-donor organ. While dialysis exposure limited to 6 to 12 months may not significantly impact post-transplant outcomes, longer period of dialysis has been shown to increase the risk of mortality, delayed graft function, acute rejection, and death-censored graft loss. The benefits of preemptive transplantation also extend to different age groups and end-stage kidney disease (ESKD) diagnoses. However, multiple barriers have prevented wider adoption of preemptive transplantation as the primary treatment of ESKD around the world. Timely preparation for ESKD and identification of living donors should be encouraged in all patients with advanced chronic kidney disease to increase the chance of preemptive transplantation.

AB - The benefits of preemptive kidney transplantation are manifold. By avoiding complications associated with dialysis, preemptive kidney transplantation offers significant benefits in terms of patient welfare and societal cost-saving. Patients transplanted preemptively also tend to enjoy better patient and graft survival, especially when done with a living-donor organ. While dialysis exposure limited to 6 to 12 months may not significantly impact post-transplant outcomes, longer period of dialysis has been shown to increase the risk of mortality, delayed graft function, acute rejection, and death-censored graft loss. The benefits of preemptive transplantation also extend to different age groups and end-stage kidney disease (ESKD) diagnoses. However, multiple barriers have prevented wider adoption of preemptive transplantation as the primary treatment of ESKD around the world. Timely preparation for ESKD and identification of living donors should be encouraged in all patients with advanced chronic kidney disease to increase the chance of preemptive transplantation.

KW - Graft survival

KW - Patient selection

KW - Patient survival

KW - Transplant outcomes

UR - http://www.scopus.com/inward/record.url?scp=84868553451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868553451&partnerID=8YFLogxK

U2 - 10.1016/j.nephro.2012.06.004

DO - 10.1016/j.nephro.2012.06.004

M3 - Review article

C2 - 22841863

AN - SCOPUS:84868553451

VL - 8

SP - 428

EP - 432

JO - Nephrologie et Therapeutique

JF - Nephrologie et Therapeutique

SN - 1769-7255

IS - 6

ER -